PERROTTA, CRISTIANA
PERROTTA, CRISTIANA
Dipartimento di Scienze Biomediche e Cliniche
Secretory Acid Sphingomyelinase in Children and Adolescents With Type 1 Diabetes
2026 C. Mameli, A. Bolchini, C. Ferrigno, P.M. Roux, A. Arcari, S. Zecchini, A. Napoli, F.C. Redaelli, M. Macedoni, A. Petitti, G. Zuccotti, E. Clementi, C. Perrotta
Immunosenescence in skeletal muscle: The role-play in cancer cachexia chessboard
2025 M. Giovarelli, E. Mocciaro, C. Carnovale, D. Cervia, C. Perrotta, E. Clementi
The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recovery
2025 M. Giovarelli, S. Zecchini, S.R. Casati, L. Lociuro, O. Gjana, L. Mollica, E. Pisanu, H.D. Mbissam, O. Cappellari, C. De Santis, A. Arcari, A. Bigot, G. Clerici, E. Catalani, S. Del Quondam, A. Andolfo, C. Braccia, M.G. Cattaneo, C. Banfi, D. Brunetti, E. Mocciaro, A. De Luca, E. Clementi, D. Cervia, C. Perrotta, C. De Palma
Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy
2025 C. Perrotta, C. Carnovale, M. Pozzi, C. De Palma, D. Cervia, M. Nobile, E. Clementi
Revisiting the alpha-synuclein paradox in melanoma-Parkinson’s disease connection: more than a tale of two cell fates
2025 J. Aiello, R. Zamarato, C. Moscheni, C. Perrotta, M. Clerici, D. Trabattoni, M. Biasin, F. Limanaqi
Mechanosensitive ion channel Piezo1 modulates the response of rat hippocampus neural stem cells to rapid stretch injury
2025 E. Mocciaro, M. Kidd, K. Johnson, E. Bishop, K. Johnson, Y.P. Zeng, C. Perrotta, M. Micci
Targeting mitochondrial dynamics to tackle Duchenne Muscular Dystrophy progression
2024 S.R. Casati, O. Gjana, S. Zecchini, M. Giovarelli, C. Perrotta, M. Caccia, S. Barozzi, Z. Lavagnino, S. Falcone, C. Gentil, F. Piétri-Rouxel, C. De Palma
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy
2024 L. Lociuro, S.R. Casati, O. Gjana, S. Zecchini, M. Giovarelli, C. Perrotta, C. De Palma
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy
2024 L. Lociuro, S.R. Casati, O. Gjana, S. Zecchini, M. Giovarelli, C. Perrotta, C. De Palma
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy
2024 L. Lociuro, S.R. Casati, O. Gjana, S. Zecchini, M. Giovarelli, C. Perrotta, C. De Palma
Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling
2024 D. Cervia, S. Zecchini, L. Pincigher, P. Roux-Biejat, C. Zalambani, E. Catalani, A. Arcari, S. Del Quondam, K. Brunetti, R. Ottria, S. Casati, C. Vanetti, M.C. Barbalace, C. Prata, M. Malaguti, S.R. Casati, L. Lociuro, M. Giovarelli, E. Mocciaro, S. Falcone, C. Fenizia, C. Moscheni, S. Hrelia, C. De Palma, E. Clementi, C. Perrotta
Mitochondria and Reactive Oxygen Species: The Therapeutic Balance of Powers for Duchenne Muscular Dystrophy
2024 S.R. Casati, D. Cervia, P. Roux-Biejat, C. Moscheni, C. Perrotta, C. De Palma
SRT2104, a new SIRT1 activator, is an effective metabolic enhancer that promotes muscle recovery in DMD
2024 M. Giovarelli, S. Zecchini, S. Casati, G. Clerici, L. Mollica, M. Cattaneo, D. Brunetti, C. Banfi, C. Perrotta, C. DE PALMA
Tailored graphene nanoparticles for biomedical application: preliminary in vitro characterization of the functionality in model cell lines
2024 C. Moscheni, P. Sartori, K. Hu, S. Zecchini, L. Brambilla, A. Arcari, A. Napoli, E. Mocciaro, M. Uboldi, L. Zema, C. Perrotta, C. Castiglioni
SRT2104, a new SIRT1 activator, is an effective metabolic enhancer that promotes muscle recovery in DMD
2023 M. Giovarelli, S. Zecchini, S. Casati, G. Clerici, L. Mollica, M. Cattaneo, D. Brunetti, C. Banfi, C. Perrotta, C. DE PALMA
Development of Tailored Graphene Nanoparticles: Preparation, Sorting and Structure Assessment by Complementary Techniques
2023 K. Hu, L. Brambilla, P.M. Sartori, C. Moscheni, C. Perrotta, L. Zema, C. Bertarelli, C. Castiglioni
Insights into the Safety and Versatility of 4D Printed Intravesical Drug Delivery Systems
2023 M. Uboldi, C. Perrotta, C. Moscheni, S. Zecchini, A. Napoli, C. Chiara, A. Gazzaniga, A. Melocchi, L. Zema
Targeting mitochondrial dynamics to tackle duchenne muscular dystrophy progression
2023 S.R. Casati, O. Gjana, S. Zecchini, M. Giovarelli, E. Clementi, C. Perrotta, C. De Palma
Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
2023 C. Perrotta, C. Fenizia, C. Carnovale, M. Pozzi, D. Trabattoni, D. Cervia, E. Clementi
Neuroprotective role of plumbagin on eye damage induced by high-sucrose diet in adult fruit fly Drosophila melanogaster
2023 E. Catalani, S. Del Quondam, K. Brunetti, A. Cherubini, S. Bongiorni, A.R. Taddei, S. Zecchini, M. Giovarelli, C. De Palma, C. Perrotta, E. Clementi, G. Prantera, D. Cervia